Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease

被引:30
作者
Dart, A [1 ]
Sherrard, B [1 ]
Simpson, H [1 ]
机构
[1] BAKER MED RES INST, MELBOURNE, VIC 3181, AUSTRALIA
关键词
apolipoprotein E; coronary heart disease; glucose; triglyceride; postprandial;
D O I
10.1016/S0021-9150(96)06062-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apolipoprotein E phenotypes and fasting lipid and other biochemical parameters were determined in 51 patients with recently diagnosed coronary heart disease (CHD) and 164 control subjects. The age of the participants was 62.5 +/- 6.6 (S.D.) and 63% were male. Forty-eight CHD cases and 51 control subjects were also studied for 8 h after a fat-rich meal. Apo E phenotypes did not differ significantly between CHD cases and control subjects although there was a tendency for under-representation of E2/E3 in the cases (6% versus 16%). Fifteen CHD cases and 37 (of 164) control subjects had at least one epsilon 4 allele. Fasting plasma triglyceride concentrations were not different between CHD cases and controls but were significantly elevated in subjects with an epsilon 4 allele. CHD cases did, however, have a significantly elevated Easting insulin compared with controls. Postprandial triglyceride responses were not different between CHD cases and controls. However, postprandial triglyceride responses were elevated in subjects (CHD cases and controls) who had an epsilon 4 allele. In multivariate analysis, both epsilon 4 allele status and body mass index (BMI) were significant determinants of postprandial triglyceride responses. Postprandial glucose responses were also elevated in subjects with an epsilon 4 allele. When comparison of CHD cases and controls was restricted to those without an epsilon 4 allele, CHD cases showed a borderline significant (P = 0.05) difference in time course from controls, with a slower decline in plasma triglyceride from the peak response. Fasting and postprandial triglyceride and postprandial glucose responses are strongly dependent on the presence of an epsilon 4 allele. The elevation in postprandial triglyceride responses associated with an epsilon 4 allele can obscure differences associated with the presence of CHD and suggests that although elevated postprandial triglyceride response may be a risk factor for CHD, it is not the major reason for the association between the possession of an epsilon 4 allele and coronary disease. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:161 / 170
页数:10
相关论文
共 54 条
[1]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[2]   PLASMA TRIGLYCERIDE AS A RISK FACTOR FOR CORONARY HEART-DISEASE - THE EPIDEMIOLOGIC EVIDENCE AND BEYOND [J].
AUSTIN, MA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (02) :249-259
[3]   Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele [J].
Bergeron, N ;
Havel, RJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01) :65-72
[4]   ASSOCIATION OF PLASMA TRIGLYCERIDE AND C-PEPTIDE WITH CORONARY HEART-DISEASE IN JAPANESE-AMERICAN MEN WITH A HIGH PREVALENCE OF GLUCOSE-INTOLERANCE [J].
BERGSTROM, RW ;
LEONETTI, DL ;
NEWELLMORRIS, LL ;
SHUMAN, WP ;
WAHL, PW ;
FUJIMOTO, WY .
DIABETOLOGIA, 1990, 33 (08) :489-496
[5]  
BOERWINKLE E, 1994, AM J HUM GENET, V54, P341
[6]  
BOUCHIER IA, 1961, LANCET, V1, P363
[7]   THE EFFECT OF FASTING TRIACYLGLYCERIDE CONCENTRATION AND APOLIPOPROTEIN-E POLYMORPHISM ON POSTPRANDIAL LIPEMIA [J].
BROWN, AJ ;
ROBERTS, DCK .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (06) :1737-1744
[8]   IS THE LEVEL OF SERUM TRIGLYCERIDE A SIGNIFICANT PREDICTOR OF CORONARY DEATH IN NORMOCHOLESTEROLEMIC SUBJECTS - THE PARIS PROSPECTIVE-STUDY [J].
CAMBIEN, F ;
JACQUESON, A ;
RICHARD, JL ;
WARNET, JM ;
DUCIMETIERE, P ;
CLAUDE, JR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 124 (04) :624-632
[9]  
CARLSON LA, 1985, ACTA MED SCAND, V218, P207
[10]   THE TRIGLYCERIDE ISSUE - A VIEW FROM FRAMINGHAM [J].
CASTELLI, WP .
AMERICAN HEART JOURNAL, 1986, 112 (02) :432-437